UK markets closed

Research Solutions, Inc. (61I.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
2.7000+0.1000 (+3.85%)
As of 08:32AM CEST. Market open.
Full screen
Previous close2.6000
Open2.7000
Bid2.6000 x N/A
Ask2.6800 x N/A
Day's range2.7000 - 2.7000
52-week range1.7900 - 3.1200
Volume50
Avg. volume4
Market cap91.938M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • PR Newswire

    Research Solutions Reports Fiscal Third Quarter 2024 Results

    Research Solutions, Inc. (NASDAQ: RSSS), a trusted partner providing cloud-based workflow solutions to accelerate research for R&D-driven organizations, reported financial results for its fiscal third quarter ended March 31, 2024.

  • PR Newswire

    Research Solutions to Announce Third Quarter Fiscal 2024 Results on Thursday, May 9, 2024

    Research Solutions, Inc. (NASDAQ: RSSS), a pioneer in providing cloud-based workflow solutions for R&D driven organizations, will hold a conference call to discuss its financial results for the fiscal 2024 third quarter ended March 31, 2024, on Thursday, May 9, 2024, at 5:00 p.m. ET. A press release containing the company's financial results will be issued following the market close and prior to the call.

  • PR Newswire

    Research Solutions Unveils AI Platform for Automated Clinical Trial Landscape Reports

    Research Solutions (NASDAQ: RSSS), a trusted partner providing cloud-based workflow solutions to accelerate research for R&D-driven organizations, today launches their new Clinical Trial Landscape software solution, making clinical trial information more accessible, insightful, and actionable. Clinical trials are essential research studies that assess the efficacy and safety of medical interventions, informing regulatory decisions, guiding healthcare practices, and advancing medical knowledge an